Anti-cancer monotherapy using sa-4-1bbl
AssigneesUniversity of Louisville Research Foundation, Inc., Fascure Therapeutics, LLC
InventorsHaval SHIRWAN, Esma S. YOLCU, Rajesh SHARM
Life of this patent
Estimating the term…
Abstract
Described herein are methods for treating and preventing cancer. In particular, described herein are methods using SA-4-1BBL as a monotherapy agent to treat, prevent or reduce the risk of cancer, treat, prevent, or reduce the risk of tumorigenesis, and treat, prevent, or reduce the risk of post-surgical tumor recurrence. SA-4-1BBL for use as a monotherapy in such methods also is provided.
Claims16
A monotherapy method of preventing or treating a cancer, comprising administering to a subject in need thereof an effective amount of SA-4-1BBL, wherein the monotherapy method does not include administering to the subject an antigen associated with the cancer.
A monotherapy method of reducing the risk of tumorigeneses, comprising administering to a subject in need thereof, an effective amount of SA-4-1BBL, wherein the monotherapy method does not include administering to the subject an antigen associated with the tumor.
A monotherapy method of reducing the risk of tumor recurrence, comprising administering to a subject in need thereof, an effective amount of SA-4-1BBL, wherein the monotherapy method does not include administering to the subject an antigen associated with the tumor.
A method according to claim 4, wherein the subject has undergone surgical removal of tumor cells, chemotherapy, and/or cancer irradiation treatment.
An SA-4-1-BBL conjugate having the amino acid sequence set forth in FIG. 8A or FIG. 8B.
A SA-4-1BBL conjugate for a monotherapy method for preventing or treating a cancer, reducing the risk of tumorigeneses, and/or reducing the risk of tumor recurrence, wherein the conjugate has the amino acid sequence set forth in FIG. 8A or FIG. 8B, and the monotherapy method does not include administering to the subject an antigen associated with the cancer or tumor.
Dependencies are inferred from the claim text.